Krakoff, I.H. and Murphy, M.L.: Hyperuricemia in neoplastic disease in children; prevention with allopurinol a xanthine oxidase inhibitor . J. Pediat.41: 52, 1968.
5.
Holland, P. and Holland, N.H.: Prevention and management of acute hyperuricemia in childhood leukemia . Pediatrics72: 358, 1968.
6.
Merrill, D.: Uremia following x-ray therapy in leukemia. New Eng. J. Med.222: 94, 1940.
7.
Rundles, R.W. , Wyngaarden, J.B., Hitchings , G.H., Elion, G.B. and Silberman , H.: Effects of a xanthine oxidase inhibitor on thiopurine metabolism, hyperuricemia and gout . Trans. Assn. Amer. Physicians76: 126, 1963.
8.
Metz, E.N. and Silberman , H.R.: Allopurinol in treatment of gout. Ann. Intern. Med.64: 229, 1966.
9.
Krakoff, I.H. and Meyer, R.L.: Prevention of hyperuricemia in leukemia and lymphoma. JAMA193: 89, 1965.
10.
Healey, L.L. : Allopurinol in the treatment of hyperuricemia and gout. Northwest Med.65: 400,1966.
11.
Vogler, W.R. , Bain, J.A., Huguley , C.M., Jr., Palmer, H.G., Jr. and Lowery , M.E.: Metabolic and therapeutic effects of allopurinol in patients with leukemia and gout. Amer. J. Med.40: 548, 1966.